UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: July 12, 2011
MedQuist Holdings Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-35069 | 98-0676666 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer I.D. No.) | ||
9009 Carothers Parkway Franklin, Tennessee |
37067 | |||
(Address of principal executive offices) | (Zip Code) |
(866) 295-4600
Registrants telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
Attached as Exhibit 99.1 is an investor presentation dated July 12, 2011.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit |
Description | |
99.1 | Investor Presentation dated July 12, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MedQuist Holdings Inc. | ||||
By | /s/ Mark R. Sullivan | |||
Name: | Mark R. Sullivan | |||
Title: | General Counsel & Chief Compliance Officer |
Date: July 12, 2011
Exhibit Index
Exhibit |
Description | |
99.1 | Investor Presentation dated July 12, 2011 |